Skip to content

Education Against Tobacco Randomized Trial

Medical-student-delivered Smoking Prevention Program for Secondary Schools: The Education Against Tobacco Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02697409
Enrollment
20000
Registered
2016-03-03
Start date
2016-03-31
Completion date
2019-07-31
Last updated
2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescents, Prevention, Schools, Tobacco

Brief summary

A two armed randomized trial is evaluating the effect of the medical-student-delivered school-based intervention Education Against Tobacco on the smoking behavior of adolescents in 7th grade of secondary school. The primary endpoint is the change in smoking prevalence between the two groups.

Interventions

BEHAVIORALEducation Against Tobacco intervention

Sponsors

University Hospital Tuebingen
CollaboratorOTHER
Universities of Giessen and Marburg Lung Center
CollaboratorUNKNOWN
University of Giessen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Pupils of 7th grade of regular secondary schools in Germany

Exclusion criteria

* Not fulfilling the inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
Smoking prevalence measured via questionnaire.24 months post baselineThe difference in smoking prevalence at 24 months follow-up is the primary endpoint measured via questionnaires.

Secondary

MeasureTime frameDescription
Relevant differences due to the theory of planned behaviour between the two groups measured via questionnaire.24 months follow-upDifference in attitude towards smoking between the two groups at 24 months follow-up measured via questionnaires.
Changes in smoking behavior24 months post baselineThe changes in smoking behavior (smoking onset, quitting) are studied as a secondary outcome measure.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026